Transplantation of Descemet’s Membrane with Endothelium and Subsequent Cataract Phacoemulsification under the Control of Intraoperative Optical Coherence Tomography in Patient with of Chandler’s Iridocorneal Endothelial Syndrome Manifestation after Laser Keratorefractive Surgery. Clinical Case

The article describes a clinical case of a patient who underwent LASIK surgery to correct hyperopia in both eyes. In the early postoperative period, episodes of increased intraocular pressure up to 27 mm Hg were noted, which were relieved with medication. In the late postoperative period, severe corneal syndrome and decreased visual acuity appeared. After a thorough inspection on OU a diagnosis was put forward: Ocular hypertension. Condition after keratorefractive surgery (LASIK), primary Fuchs’ endothelial corneal dystrophy, mild hyperopia, early cataract, OS fluid accumulation under corneal flap, mild amblyopia. The decision was made to transplant the endothelium with Descemet’s membrane to the OS. The operation went as usual, the donor Descemet’s membrane was fully flattened, but it did not result in a reduction of corneal stromal edema and disappearance of the intracorneal gap filled with fluid. The patient was administered additional hypotensive therapy after which positive dynamics of stromal edema were observed. Later, the patient underwent cataract phacoemulsification under the control of intraoperative optical coherence tomography. The article presents the analysis of this clinical case, discusses the choice of treatment tactics and specifies the diagnosis as a manifestation of Chandler’s iridocorneal endothelial syndrome after keratorefractive surgery.

1. Autrata R, Rehurek J. Laser-assisted subepithelial keratectomy for myopia: two-year follow-up. J Cataract Refract Surg. 2003 Apr;29(4):661–668. doi: 10.1016/s0886-3350(02)01897-7.

2. Celik U, Bozkurt E, Celik B, Demirok A, Yilmaz OF. Pain, wound healing and refractive comparison of mechanical and transepithelial debridement in photorefractive keratectomy for myopia: results of 1 year follow-up. Cont Lens Anterior Eye. 2014 Dec;37(6):420–426. doi: 10.1016/j.clae.2014.07.001.

3. Gamaly TO, El Danasoury A, El Maghraby A. A prospective, randomized, contralateral eye comparison of epithelial laser in situ keratomileusis and photorefractive keratectomy in eyes prone to haze. J Refract Surg. 2007 Nov;23(9 Suppl):S1015–S1020. doi: 10.3928/1081-597X-20071102-07.

4. Kahuam-López N, Navas A, Castillo-Salgado C, Graue-Hernandez EO, Jimenez-Corona A, Ibarra A. Laser-assisted in-situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism. Cochrane Database Syst Rev. 2020 Apr 7;4(4):CD012946. doi: 10.1002/14651858.CD012946.pub2.

5. Kuo CY, Chang YF, Chou YB, Hsu CC, Lin PY, Liu CJ. Delayed onset of pressure-induced interlamellar stromal keratitis in a patient with recurrent uveitis: A case report. Medicine (Baltimore). 2017 Dec;96(48):e8958. doi: 10.1097/MD.0000000000008958.

6. Malyugin BE, Gelyastanov AM, Antonova OP. Tissue-sparing technique of transplantation of Descemet’s membrane with a monolayer of endothelial cells for the treatment of endothelial dysfunction. Russian Journal of Transplantology and Artificial Organs. 2019;21(S):157.

7. Maliugin BÉ, Shilova NF, Anisimova NS, Antonova OP. Transplantation of endothelium and Descemet’s membrane. Russian Annals of Ophthalmology. 2019;135(1):98–103 (In Russ.). doi: 10.17116/oftalma201913501198.

8. Malyugin BE, Antonova OP, Skorodumova LO, Sharova LI, Selezneva OV, Danilenko SA, Kostryukova ES. Results of the study of genetic markers associated with primary endothelial corneal dystrophy (Fuchs). Fyodorov Journal of Ophthalmic Surgery. 2016;4:44–50 (In Russ.). doi: 10.25276/0235-4160-2016-4-44-50.

9. Shields MB. Progressive essential iris atrophy, Chandler’s syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease. Surv Ophthalmol. 1979 Jul-Aug;24(1):3–20. doi: 10.1016/0039-6257(79)90143-7.

10. Laganowski HC, Kerr Muir MG, Hitchings RA. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992 Mar;110(3):346–350. doi: 10.1001/archopht.1992.01080150044025.

11. Eagle RC Jr, Font RL, Yanoff M, Fine BS. Proliferative endotheliopathy with iris abnormalities. The iridocorneal endothelial syndrome. Arch Ophthalmol. 1979 Nov;97(11):2104–2111. doi: 10.1001/archopht.1979.01020020422002.

12. Lobo AM, Rhee DJ. Delayed interval of involvement of the second eye in a male patient with bilateral Chandler’s syndrome. Br J Ophthalmol. 2012 Jan;96(1):134–135, 146–147. doi: 10.1136/bjo.2009.177931.

13. Alvarado JA, Underwood JL, Green WR, Wu S, Murphy CG, Hwang DG, Moore TE, O’Day D. Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol. 1994 Dec;112(12):1601–1609. doi: 10.1001/archopht.1994.01090240107034.

14. Tsai CS, Ritch R, Straus SE, Perry HD, Hsieh FY. Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome. Arch Ophthalmol. 1990 Nov;108(11):1572–1576. doi: 10.1001/archopht.1990.01070130074034.

15. Sacchetti M, Mantelli F, Marenco M, Macchi I, Ambrosio O, Rama P. Diagnosis and Management of Iridocorneal Endothelial Syndrome. Biomed Res Int. 2015;2015:763093. doi: 10.1155/2015/763093.

16. Kymionis GD, Kontadakis GA, Agorogiannis GI, Bennett M, Angelidou F. Descemet stripping automated endothelial keratoplasty combined with phacoemulsification in Chandler syndrome. Eur J Ophthalmol. 2011 Jul-Aug;21(4):495–497. doi: 10.5301/EJO.2010.6210.

17. Yur’eva TN. Regularity and mechanisms of irido-corneal endothelial syndrome formation. Sibirskii meditsinskii zhurnal. 2009;8:53–55 (In Russ.).

18. Lasareva AK, Kuleshova ON, Aidagulova SV, Dulidova VV, Chernykh VV. Differential diagnosis and treatment of Chandler iridocorneal endothelial syndrome. Russian Annals of Ophthalmology. 2018;134(1):77–84 (In Russ.). doi: 10.17116/oftalma2018134177-84.

19. Buxton JN, Lash RS. Results of penetrating keratoplasty in the iridocorneal endothelial syndrome. Am J Ophthalmol. 1984 Sep 15;98(3):297–301. doi: 10.1016/0002-9394(84)90319-2.

20. Price MO, Price FW Jr. Descemet stripping with endothelial keratoplasty for treatment of iridocorneal endothelial syndrome. Cornea. 2007 May;26(4):493–497. doi: 10.1097/ICO.0b013e318030d274.

21. Siddharthan KS, Agrawal A, Patro S, Kumar Reddy J. Long-term clinical outcomes after Descemet Membrane Endothelial Keratoplasty (DMEK) in Irido-Corneal Endothelial Syndrome. Am J Ophthalmol Case Rep. 2020 Aug 27;20:100894. doi: 10.1016/j.ajoc.2020.100894.

22. Wu J, Dong X, Ouyang C, Ji J, Xie L, Hou C, Huang T. Comparison of Descemet Membrane Endothelial Keratoplasty for Iridocorneal Endothelial Syndrome and Fuchs Endothelial Dystrophy. Am J Ophthalmol. 2021 Jun;226:76–82. doi: 10.1016/j.ajo.2021.01.029.

23. Fajgenbaum MA, Hollick EJ. Descemet Stripping Endothelial Keratoplasty in Iridocorneal Endothelial Syndrome: Postoperative Complications and Long-Term Outcomes. Cornea. 2015 Oct;34(10):1252–1258. doi: 10.1097/ICO.0000000000000530.

24. Alvim PT, Cohen EJ, Rapuano CJ, Chung CW, Pereira ML, Eagle RC Jr, Katz LJ, Smith AF, Laibson PR. Penetrating keratoplasty in iridocorneal endothelial syndrome. Cornea. 2001 Mar;20(2):134–140. doi: 10.1097/00003226-200103000-00003.

25. Weller JM, Tourtas T, Kruse FE. Feasibility and Outcome of Descemet Membrane Endothelial Keratoplasty in Complex Anterior Segment and Vitreous Disease. Cornea. 2015 Nov;34(11):1351–1357. doi: 10.1097/ICO.0000000000000625.

26. Huang T, Wang Y, Ji J, Gao N, Chen J. Deep lamellar endothelial keratoplasty for iridocorneal endothelial syndrome in phakic eyes. Arch Ophthalmol. 2009 Jan;127(1):33–36. doi: 10.1001/archophthalmol.2008.537.

27. Quek DT, Wong CW, Wong TT, Han SB, Htoon HM, Ho CL, Tan DT, Price FW Jr, Price MO, Mehta JS. Graft failure and intraocular pressure control after keratoplasty in iridocorneal endothelial syndrome. Am J Ophthalmol. 2015 Sep;160(3):422–429. e1. doi: 10.1016/j.ajo.2015.05.024. .

28. Ao M, Feng Y, Xiao G, Xu Y, Hong J. Clinical outcome of Descemet stripping automated endothelial keratoplasty in 18 cases with iridocorneal endothelial syndrome. Eye (Lond). 2018 Apr;32(4):679–686. doi: 10.1038/eye.2017.282.

29. Chaurasia S, Ramappa M, Garg P, Murthy SI, Senthil S, Sangwan VS. Endothelial keratoplasty in the management of irido-corneal endothelial syndrome. Eye (Lond). 2013 Apr;27(4):564–566. doi: 10.1038/eye.2012.298.

30. Mittal V, Mittal R, Maheshwari R. Combined endothelial keratoplasty and clear lens extraction for corneal decompensation in irido-corneal endothelial syndrome. Indian J Ophthalmol. 2014 May;62(5):651–653. doi: 10.4103/0301-4738.118435.

31. Hamzaoglu EC, Straiko MD, Mayko ZM, Sáles CS, Terry MA. The First 100 Eyes of Standardized Descemet Stripping Automated Endothelial Keratoplasty versus Standardized Descemet Membrane Endothelial Keratoplasty. Ophthalmology. 2015 Nov;122(11):2193–2199. doi: 10.1016/j.ophtha.2015.07.003.

32. Terry MA, Straiko MD, Veldman PB, Talajic JC, VanZyl C, Sales CS, Mayko ZM. Standardized DMEK Technique: Reducing Complications Using Prestripped Tissue, Novel Glass Injector, and Sulfur Hexafluoride (SF6) Gas. Cornea. 2015 Aug;34(8):845–852. doi: 10.1097/ICO.0000000000000479.

33. Sorkin N, Einan-Lifshitz A, Boutin T, Showail M, Borovik A, Chan CC, Rootman DS. Descemet membrane endothelial keratoplasty in iridocorneal endothelial syndrome and posterior polymorphous corneal dystrophy. Can J Ophthalmol. 2019 Apr;54(2):190–195. doi: 10.1016/j.jcjo.2018.05.012.